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SUMMARY
The variability of larval excretion impedes the parasitological diagnosis of Strongyloides stercoralis in infected individuals.
We assessed the number of larvae excreted per gram (LPG) stool in 219 samples from 38 infected individuals over
7 consecutive days before and in 470 samples from 44 persons for 21 consecutive days after ivermectin treatment
(200 μg kg−1 BW). The diagnostic sensitivity of a single stool sample was about 75% for individuals with low-intensity
infections (41 LPG) and increased to 95% for those with high-intensity infections (510 LPG). Doubling the number of
samples examined per person increased sensitivity to more than 95%, even for low-intensity infections. There was no
indication of a cyclic excretion of larvae. After treatment, all individuals stopped excreting larvae within 3 days. Larvae were
not detected during any of the following 18 days (total 388 Baermann and 388KogaAgar tests). Two stool samples, collected
on consecutive days, are recommended in settings where low or heterogeneous infection intensities are likely. In this way,
taking into account the possible biological variability in excretion, the eﬃcacy of ivermectin treatment can be assessed as
soon as 4 days after treatment.
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INTRODUCTION
Strongyloides stercoralis, a soil-transmitted nematode
found worldwide (Genta, 1989; Bethony et al. 2006),
is arguably the most neglected of all neglected
helminth infections (Olsen et al. 2009; Schär et al.
2013). Infectious S. stercoralis (L3) larvae are found
in humid soil contaminated with fecal material. From
there, the larvae penetrate the intact skin of the
human host. In resource-poor countries, environ-
mental, socio-economic and behavioural factors, and
inadequate sanitary conditions provide the ideal
circumstances for high S. stercoralis transmission
rates.
Parasitological diagnosis of S. stercoralis infection
relies on identifying larvae in stool. The Baermann
technique (Baermann, 1917) and Koga Agar culture
(Koga et al. 1991) are recommended for diagnosis,
preferably used in combination and carried out on
multiple stool samples (Khieu et al. 2013). Infections
with low numbers of excreted larvae are particularly
challenging to diagnose and can easily be missed. For
other intestinal helminths, detailed egg excretion
pattern studies have been performed, e.g. for liver
ﬂukes (Lovis et al. 2012), but information is missing
for S. stercoralis.
The eﬃcacy of ivermectin in treating S. stercoralis
has been demonstratedmany times (Marti et al. 1996;
Toma et al. 2000; Adenusi et al. 2003; Heukelbach
et al. 2004; Igual-Adell et al. 2004; Ordonez and
Angulo, 2004; Suputtamongkol et al. 2011; Khieu
et al. 2013). However, little is known about the
parasite clearance time and cessation of larvae
excretion after ivermectin treatment (Uparanukraw
et al. 1999) in endemic settings. Yet, this information
is crucial for planning and executing follow-up
examinations after treatment.
We assessed the excretion pattern of S. stercoralis
larvae by examining stool samples daily for 7 days
before and for 21 days after ivermectin treatment
(200 μg kg−1 BW, single oral dose (SOD)) in 38 and
44 infected patients, respectively.
MATERIALS AND METHODS
Ethical considerations
This study was undertaken in Preah Vihear (March
2010) and Takeo provinces (March 2011) in
Cambodia. The study protocol was approved by the
Ethics Committee of the Canton of Basel (EKBB,
21/09 dated 29 January 2009), Switzerland and by
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the National Ethics Committee Health Research
(NECHR; 033 dated 20 March 2009), Ministry of
Health, Cambodia. All participants were informed of
the purpose and process of the study. Written
informed consent was obtained from all individuals
prior to enrolment. All diagnosed infections were
treated at the end of the study, according to the
National Cambodian treatment guidelines.
Enrolment
Individuals diagnosed with S. stercoralis during a
community-based helminth survey were randomly
selected. Either the examined person alone (in Preah
Vihear) or the examined person and all persons living
in the same household (in Takeo) were enrolled.
Field procedures
Participants provided a stool sample each morning,
for 7 days (Fig. 1). Each day they received a new
labelled stool container to use for the following day.
The collected samples were transported at ambient
temperature and within 1 h to a health centre ﬁeld
laboratory where the laboratory examinations were
conducted (2–3 h after defecation).
Participants that tested positive for S. stercoralis at
least once during the 7 days were treated with a SOD
of ivermectin (200 μg kg−1 body weight) on day 7.
Daily stool collection continued for another 21 days
after treatment was given.
Laboratory procedures
Upon the sample’s arrival in the laboratory, a
quantitative Baermann test was performed
(Baermann, 1917). In brief, the stool container with
the sample was weighed. A Baermann test was set up
and the container was weighed again. The stool
sample (about 15–25 g) was placed in awire-mesh in a
funnel ﬁlled with tap water. Artiﬁcial light was used
to stimulate larval migration out of the stool into
the funnel. After 2 h, the water containing the larvae
was collected and centrifuged for 5min at 2000 rpm.
The sediment was examined under a microscope
(400× magniﬁcation) and S. stercoralis larvae were
counted.
For each stool sample, a Koga Agar culture (Koga
et al. 1991) was also performed. In brief, a hazelnut-
sized piece of stool was placed on a soft Agar plate.
It was then incubated for 48 h at 28 °C. The plates
were then rinsed and the liquid centrifuged for 2min
at 2000 rpm. The sediment was examined under a
microscope for the presence of larvae and adults.
Statistical analysis
Data were entered in Microsoft Excel, cross-checked
against original data sheets and analysed using the
statistical software, R. Strongyloides stercoralis infec-
tion intensity was calculated as larvae per gram stool
(LPG). The relationship between diagnostic sensi-
tivity and infection intensity (i.e. the mean LPG per
individual) was visually assessed using a LOWESS
smoother. Diagnostic sensitivity was calculated for
both examining a stool sample on a single day and for
examining samples collected on 2 consecutive days.
Data from participants providing samples on 6 or
more days before treatment were analysed for
periodicity in the excretion pattern. Algorithms to
detect periodicity of unknown time intervals usually
require longer time series. However, every harmonic
excretion pattern would have fewer local maxima
compared with random noise. We compared the
observed local maxima in the larvae excretion counts
within individuals with the number of local maxima
in randomly generated numbers. A local maximum
was identiﬁed when the LPG on a certain day was
higher than the counts of the previous day and the
following day.
After treatment, the infection rate was calculated
for each day as the number of patients in which at
least one S. stercoralis larva was observed divided by
the number of patients treated and followed-up. For
each observation day, the larvae reduction rate (LRR)
was calculated. We used the mean number of larvae
excreted by each individual before treatment as the
reference value. The overall LRR was calculated by
ﬁrst dividing the mean LPG for each day post
treatment by the overall LPG. The result of the
division was subtracted from 1 to get the LRR.
RESULTS
Enrolment and compliance
Altogether, 65 people were enrolled in the study
(Fig. 1). First, a baseline examination was performed.
Fig. 1. Flowchart: enrolment and follow-up of study
participants.
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Individuals testing positive for S. stercoralis were
randomly selected, as were individuals who tested
negative (to form a control group). The overall mean
age of participants was 26·7 years (range: 3–81 years).
There were 32 (49·2%) males and 33 (50·8%) females.
A total of 800 stool samples with an average weight
of 19·7 g (range: 4·3–44·7 g) were examined with the
Baermannmethod. All diagnostic results obtained by
the Baermann method were conﬁrmed by Koga Agar
culture.
Larval excretion pattern before treatment
Thirty-nine (60·0%) people were infected with
S. stercoralis. During the baseline examination,
18 (27·7%) provided 7 samples each, 14 (21·5%)
provided 6 samples each and 32 (49·2%) provided 2–5
samples each. One person (2·6%) provided only
1 sample and was excluded from the excretion pattern
analysis. The mean number of stools provided by
healthy individuals was signiﬁcantly lower than that
provided by infected persons (4·2 vs 5·6 stool
samples, P = 0·008). Altogether, 26 participants
were negative, yet one person who tested negative
at the initial examination presented a S. stercoralis
infection on the third day. That person was subse-
quently moved into the treatment group.
For the larval excretion pattern analysis, the 38
infected individuals who provided more than one
sample (median: 6 samples) were included.
Considerable variation in larvae excretion densities
was observed in the pre-treatment examinations. The
highest and lowest average densities per person
observed were 151·2 LPG (range: 28·8–410·6 LPG)
and 0·03 LPG (range 0–0·07 LPG), respectively.
Twenty-three patients (60·5%) tested positive for
larvae each day before treatment, 9 (23·7%) had 1 day
where no larvae were excreted, 4 (10·5%) had 2 days
with no larvae present and 2 (5·3%) had 3 negative
examinations.
The diagnostic sensitivity of a single-day examin-
ation was 75% for individuals with an average LPG
of 1 or less. Higher average LPGs increased diag-
nostic sensitivity. An LPG of 10 or more resulted
in sensitivities of more than 95% (Fig. 2). When
stool samples collected on 2 consecutive days were
analysed, the sensitivity increased remarkably. The
sensitivity of two samples collected on consecutive
days was 97·0% (LPG≤1) and close to 100%
(LPG510), respectively.
We found a total of 65 local maxima in the 26
individuals with 6 or more stool examinations before
treatment, which corresponds exactly to the expected
number of local maxima in randomly generated
Fig. 2. Diagnostic sensitivity of examining a single stool sample (black dots) and two samples collected on consecutive
days (grey dots) by mean LPG count. Small random noise was added to alleviate overplotting. Lines represent the
corresponding locally weighted scatterplot smoothing (LOWESS) curves.
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numbers (median 65, 95% CI: 60–71), indicating no
cyclic larvae release.
Larval excretion pattern after ivermectin treatment
On the ﬁrst day of follow-up after treatment, 16
(33·3%) participants provided a stool sample, 9
(56·3%) of which were found to be positive for larvae
(Fig. 3a). On the second day, 18 (37·5%) provided a
sample, of which 4 (22·2%) still tested positive. On
the third day, none of the 15 (31·3%) samples
provided yielded any S. stercoralis. From day 3 to
21 days after treatment, an average of 17 samples
(35·4%) was returned each day, with a range of 11 to
24 samples per day. A total of 310 stool samples
were received and analysed with Baermann and Koga
Agar culture. Not a single larva was detected. All
the results obtained by Baermann method were
conﬁrmed by the Koga Agar culture method.
From all the samples provided post-treatment, the
LRR was calculated. The LRR increased dramati-
cally to 92 and 99%, 24 and 48 h after treatment,
respectively (Fig. 3b). From the third day onwards,
all stool examinations remained negative.
(a)
(b)
Fig. 3. (a) Strongyloides stercoralis infection rate after ivermectin treatment. (b) Larvae reduction rate after ivermectin
treatment.
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DISCUSSION
Strongyloides stercoralis remains one of the most
neglected and under-reported helminthic infec-
tions (Olsen et al. 2009; Schär et al. 2013). The
irregular excretion of larvae, as well as the very low
sensitivity of standard O&P examination procedures
for S. stercoralis, requiring time-consuming special
methods, are the main factors contributing to this
under-reporting. Our results show that there is
considerable variation in the numbers of S. stercoralis
larvae excreted. Individuals with high-intensity in-
fections (more than 10 larvae per gram stool) tended
to present a positive result on all days of examination.
Uparanukraw and colleagues (Uparanukraw et al.
1999) also documented variation of larval excretion,
yet the underlying mechanisms accounting for this
variation remain unclear (Jones, 1950; Jones and
Abadie, 1954; Leighton and MacSween, 1990). As
expected, we showed that diagnostic sensitivity in-
creases with higher infection intensity. Diagnosing
low-intensity chronic infections remains a major
challenge and are likely to be missed by a single
examination.
To further increase diagnostic sensitivity and to
minimize false-negative results, it is important to
analyse multiple stool samples on consecutive days.
We demonstrated that sensitivity increases substan-
tially if 2 samples are analysed. For several other
helminthic infections, others have recommended that
at least 3 samples on consecutive days be examined
(Marti and Koella, 1993; Dreyer et al. 1996; Knopp
et al. 2008). For S. stercoralis, it is essential to target
eradication of the pathogen rather than reducing
infection intensity, as the ability of auto-infection
can sustain the infection in the host. Grove reported
patients testing positive after 2 years, even if the
initial follow-up after treatment failed to show an
S. stercoralis infection (Grove, 1982).
When comparing the local maxima of larvae
excreted with the maxima of random numbers, we
could not establish a diﬀerence, which indicates that
there is no cyclic pattern underlying the excretion
of larvae. We also compared the diagnostic sensitivity
of analysing 2 samples on consecutive days with
the diagnostic sensitivity of analysing 2 samples
with a sampling-free day in-between. As we did not
detect a cyclic pattern, we expected the sensitivities
to be approximately the same. This is reﬂected
in our results. The diagnostic sensitivity of two
samples with a sampling-free day in-between was
99% (compared with 97% on consecutive days). This
diﬀerence is likely due to chance, given the small
sample size. Another possible explanation might be
the number of low-intensity infections, of which
some had 2 consecutive days with no larvae excreted.
Consequently, one would expect a further increase
in sensitivity when analysing stool samples obtained
on 3 consecutive days.
Ivermectin treatment proved to be very eﬀective.
In all infected participants, larvae excretion subsided.
We investigated, for the ﬁrst time, what happens
directly after treatment. In our study, all individuals
who received treatment (200 μg kg−1, SOD) stopped
excreting larvae 72 h after treatment, at the latest.
Larvae could not be detected in any of the partici-
pants during the remaining 19 days following
treatment. However, the absence of larvae does not
ensure that the parasite has been eradicated from the
host, which, in contrast to other helminths, should
be the target of S. stercoralis treatment, as a few
surviving larvae may lead parthenogenetically again
to high infection densities (Satoh and Kokaze, 2004;
Requena-Mendez et al. 2013). However, current
diagnostic parasitological methods do not allow us to
verify this and prolonging the follow-up period is not
an option in endemic areas, as the possibility of re-
infection will still exist.
The standard Baermann method does not quantify
the infection and only reports the presence or absence
of the pathogen. We modiﬁed the Baermann method
to calculate larvae per gram stool. Counting larvae in
a Baermann examination can be challenging, es-
pecially in cases of heavy infections, with many larvae
present. As the larvae are alive and moving, there is a
possibility of missing or double-counting larvae. The
counts might, therefore, diﬀer slightly from the true
number, yet this diﬀerence is likely to be small and
the calculated LPG values reﬂect the intensity of
infection appropriately.
Compliance tends to be an issue in these studies, as
very often participants are not able to defecate every
day. It is very important to ensure that the stool
samples provided are from the same person. If the
person was not able to defecate, the stool container
was returned empty. Furthermore, it was important
that the stool samples provided were fresh to ensure
that the larvae would still be alive.
Studies that focus on soil-transmitted helminths,
including S. stercoralis, should apply the best
available coprological diagnostic methods, like the
Baermann method and/or Koga Agar culture. This
combination of diagnostic methods, although work-
and material-intensive, would help to get more
accurate numbers on the global prevalence of
S. stercoralis. Today, most studies on helminths
either do not include S. stercoralis or use unsuitable
diagnostic approaches, which, due to the factors
stated above, leads to a severe under-reporting of
S. stercoralis worldwide (Schär et al. 2013).
In our study, we showed the importance of
examining multiple stool samples on consecutive
days because of the irregular excretion of larvae and
the danger of missing low-intensity infections.
Furthermore, we showed that treatment with iver-
mectin leads to the absence of larvae excreted within
3 days after treatment. This has implications for
planning and conducting follow-up studies. Our data
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indicate that the clearance of larvae is rapid. Even if a
possible biological variability in excretion is taken
into account, follow-up periods in ivermectin trials
can be short, i.e. 4 days.
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